From September 1st to 3rd, 2025, Shandong Binzhou Zhiyuan Biotechnology Co., Ltd., along with its subsidiary Jinan Xinzhiyuan Biotechnology Co., Ltd., made a grand appearance at the 2025 CPHI & PMEC Pharmaceutical Industry Exhibition held at the Shenzhen Convention and Exhibition Center (Futian) (Booth No.: 9i28). As a leading enterprise in the domestic biodegradation technology field, Zhiyuan Biotechnology focused on the innovative breakthroughs in the pharmaceutical raw materials and biotechnology sectors this time. It launched two new products, hydroxypropyl chitosan and carboxymethyl chitosan, on site, which attracted high attention from global professional audiences and industry partners with their outstanding performance.

With the theme of "Deepening Cooperation, Creating the Future", Zhiyuan Bio showcased its latest research and development achievements and comprehensive application solutions in cyclodextrin derivatives and chitosan derivatives at the exhibition site. The two new products demonstrated significant performance advantages in scenarios such as pharmaceutical excipients and daily chemical products - not only providing downstream customers with more environmentally friendly and efficient raw material options, but also promoting the industry's progress towards sustainable development through technological innovation.

During the exhibition, the Zhiyuan Biotechnology team had in-depth exchanges with pharmaceutical companies, research institutions and industry experts from around the world. They conducted fruitful discussions on the innovative paths and cooperation opportunities of derivative technology in various fields such as drug delivery, beauty care, and functional additives. We look forward to establishing closer collaborations with more industry partners through this international platform, and jointly promoting the industrialization and internationalization of cyclodextrin derivative technology.

Zhiyuan Biotechnology has always been dedicated to the research, production and promotion of cyclodextrin derivatives and chitosan derivatives. It has now established a complete product chain and technical service system. In the future, the company will continue to increase its research and development investment, collaborate with industry partners for innovation, and inject strong impetus into the high-quality development of the pharmaceutical and health care industries.

We sincerely invite global partners and customers to visit the 9i28 booth at Shenzhen Convention and Exhibition Center (Futian) to discuss cooperation and jointly plan for development!